Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.
$48.82 +1.49 (3.14%)
As of 03/05/2021 15:59:34 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.